UKZN Fellowship Award Recognizes Excellence in Nuclear Medicine Research

UKZN Fellowship Award Recognizes Excellence in Nuclear Medicine Research. Dr. Bawinile Hadebe, the Head of the Clinical Unit in the Nuclear Medicine Department at Inkosi Albert Luthuli Central Hospital (IALCH), has been honored with the prestigious 2023 Discovery Foundation Fellowship Award. This recognition celebrates her groundbreaking PhD research focused on “The Impact of Gallium-68 Pentixafor in Solid Tumours.”

Read Also: UKZN Status Check Online 

Research Focus

Dr. Hadebe research delves into the potential of Gallium-68 Pentixafor, a novel radiotracer targeting Chemokine receptor 4 (CXCR4), in patients with various solid tumors, including head and neck cancer, breast cancer, and gynecological malignancies. Her study aims to unveil the potential for innovative therapies targeting CXCR4 in these cancers, potentially revolutionizing treatment approaches.

Acknowledgements and Gratitude

Expressing her gratitude for the Discovery Foundation Fellowship, Dr. Hadebe emphasizes its importance in advancing her research endeavors. She acknowledges the esteemed mentors and collaborators, including Professors Ncoza Dlova and Mosa Moshabela, who have played pivotal roles in her academic journey. Additionally, she extends her thanks to the patients, co-investigators, and supervisors for their invaluable contributions and unwavering support throughout the research process.

Commitment to Advancement

Beyond her PhD, Dr. Hadebe is committed to contributing to the discovery of novel radiotracers and enhancing accessibility to targeted radionuclide therapies. She envisions forming collaborative partnerships to translate her research into tangible outcomes, demonstrating her dedication to making significant strides in healthcare accessibility and advancing cancer treatment.

Conclusion

Dr. Bawinile Hadebe receipt of the 2023 Discovery Foundation Fellowship Award underscores her exceptional contributions to nuclear medicine research. Her pioneering work not only sheds light on innovative treatment avenues for solid tumors but also exemplifies her commitment to driving impactful advancements in healthcare. With a steadfast determination to make a lasting difference, Dr. Hadebe’s endeavors promise to shape the future of cancer treatment and accessibility to novel therapies.